Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Data on genotype frequency for SNPs associated to age of smoking onset and successful smoking cessation treatment.

Pérez-Rubio G, López-Flores LA, Ramírez-Venegas A, Sansores RH, Falfán-Valencia R.

Data Brief. 2019 Apr 17;24:103893. doi: 10.1016/j.dib.2019.103893. eCollection 2019 Jun.

2.

SMALLa AIRWAY DISEASE IN COPD ASSOCIATED TO BIOMASS EXPOSURE.

Ramírez-Venegas A, Torres-Duque CA, Guzmán-Bouilloud NE, González-García M, Sansores RH.

Rev Invest Clin. 2019;71(1):70-78. doi: 10.24875/RIC.18002652. Review.

3.

Genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment: A pilot study.

Pérez-Rubio G, López-Flores LA, García-Carmona S, García-Gómez L, Noé-Díaz V, Ambrocio-Ortiz E, Nava-Quiroz KJ, Morales-González F, Del Angel-Pablo AD, Ramírez-Venegas A, Sansores RH, Falfán-Valencia R.

Gene. 2019 Apr 30;694:93-96. doi: 10.1016/j.gene.2019.01.036. Epub 2019 Feb 6.

PMID:
30738094
4.

Varenicline for long term smoking cessation in patients with COPD.

Hernández Zenteno RJ, Lara DF, Venegas AR, Sansores RH, Pineda JR, Trujillo FF, Pérez Padilla JR, Matera MG, Cazzola M.

Pulm Pharmacol Ther. 2018 Dec;53:116-120. doi: 10.1016/j.pupt.2018.11.001. Epub 2018 Nov 3.

PMID:
30399395
5.

Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area.

Ramírez-Venegas A, Velázquez-Uncal M, Pérez-Hernández R, Guzmán-Bouilloud NE, Falfán-Valencia R, Mayar-Maya ME, Aranda-Chávez A, Sansores RH.

Int J Chron Obstruct Pulmon Dis. 2018 May 25;13:1727-1734. doi: 10.2147/COPD.S156409. eCollection 2018.

6.

Data on polymorphisms in CYP2A6 associated to risk and predispose to smoking related variables.

López-Flores LA, Pérez-Rubio G, Ramírez-Venegas A, Ambrocio-Ortiz E, Sansores RH, Falfán-Valencia R.

Data Brief. 2017 Sep 13;15:86-91. doi: 10.1016/j.dib.2017.09.013. eCollection 2017 Dec.

7.

Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.

Pérez-Rubio G, López-Flores LA, Ramírez-Venegas A, Noé-Díaz V, García-Gómez L, Ambrocio-Ortiz E, Sánchez-Romero C, Hernández-Zenteno RJ, Sansores RH, Falfán-Valencia R.

Gene. 2017 Sep 10;628:205-210. doi: 10.1016/j.gene.2017.07.051. Epub 2017 Jul 20.

PMID:
28734893
8.

Using PICO Methodology to Answer Questions About Smoking in COPD Patients.

Jiménez Ruiz CA, Buljubasich D, Riesco Miranda JA, Acuña Izcaray A, de Granda Orive JI, Chatkin JM, Zabert G, Guerreros Benavides A, Paez Espinel N, Noé V, Sánchez-Angarita E, Núñez-Sánchez I, Sansores RH, Casas A, Palomar Lever A, Alfageme Michavila I.

Arch Bronconeumol. 2017 Nov;53(11):622-628. doi: 10.1016/j.arbres.2017.04.012. Epub 2017 May 27. English, Spanish.

9.

Déficit en la asistencia médica farmacológica y de seguimiento en el tratamiento del tabaquismo en México.

Sansores RH, Delgado-Ginebra I, García-Gómez LA, Noe-Díaz V, Ramírez-Venegas A, Conteras-Romero R, Lozano-Vargas M, Pérez-Márquez LE.

Salud Publica Mex. 2016 Nov-Dec;58(6):599-600. doi: 10.21149/spm.v58i6.8077. Spanish. No abstract available.

PMID:
28225933
10.

Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity.

Pérez-Rubio G, Ramírez-Venegas A, Noé Díaz V, García Gómez L, Elvira Fabián K, García Carmona S, López-Flores LA, Ambrocio-Ortiz E, Contreras Romero R, Alcantar-Ayala N, Sansores RH, Falfán-Valencia R.

PLoS One. 2017 Jan 19;12(1):e0170019. doi: 10.1371/journal.pone.0170019. eCollection 2017.

11.

SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways.

Pérez-Rubio G, Pérez-Rodríguez ME, Fernández-López JC, Ramírez-Venegas A, García-Colunga J, Ávila-Moreno F, Camarena A, Sansores RH, Falfán-Valencia R.

Pharmacogenomics. 2016 Jul;17(10):1145-1158. Epub 2016 Jun 29.

12.

Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study.

Sansores RH, Ramírez-Venegas A, Arellano-Rocha R, Noé-Díaz V, García-Gómez L, Pérez Bautista O, Velázquez Uncal M.

Ther Adv Respir Dis. 2016 Oct;10(5):383-90. doi: 10.1177/1753465816654823. Epub 2016 Jun 27.

13.

Genetic Variants in IL6R and ADAM19 are Associated with COPD Severity in a Mexican Mestizo Population.

Pérez-Rubio G, Silva-Zolezzi I, Fernández-López JC, Camarena Á, Velázquez-Uncal M, Morales-Mandujano F, Hernández-Zenteno Rde J, Flores-Trujillo F, Sánchez-Romero C, Velázquez-Montero A, Espinosa de Los Monteros C, Sansores RH, Ramírez-Venegas A, Falfán-Valencia R.

COPD. 2016 Oct;13(5):610-5. doi: 10.3109/15412555.2016.1161017. Epub 2016 Apr 14.

PMID:
27078193
14.

Nicotine Addiction Development: From Epidemiology to Genetic Factors.

Pérez-Rubio G, Sansores R, Ramírez-Venegas A, Camarena Á, Pérez-Rodríguez ME, Falfán-Valencia R.

Rev Invest Clin. 2015 Nov-Dec;67(6):333-43. Review.

15.

COPD in women: susceptibility or vulnerability?

Sansores RH, Ramírez-Venegas A.

Eur Respir J. 2016 Jan;47(1):19-22. doi: 10.1183/13993003.01781-2015. No abstract available.

16.

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers.

Sansores RH, Velázquez-Uncal M, Pérez-Bautista O, Villalba-Caloca J, Falfán-Valencia R, Ramírez-Venegas A.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 2;10:2357-63. doi: 10.2147/COPD.S91742. eCollection 2015.

17.

Impacto del consejo breve para dejar de fumar.

García-Gómez L, Sansores RH, Noé Díaz V, Urdapilleta-Herrera E, González-Rojas G, Pérez-Márquez LE, Ramírez Venegas A.

Salud Publica Mex. 2015 Sep-Oct;57(5):366-7. Spanish. No abstract available.

PMID:
26544996
18.

Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population.

Hernández-Montoya J, Pérez-Ramos J, Montaño M, Ramírez-Venegas A, Sansores RH, Pérez-Rubio G, Velázquez-Uncal M, Camarena A, Ramos C, Falfán-Valencia R.

Biomark Med. 2015;9(10):979-88. doi: 10.2217/bmm.15.75. Epub 2015 Oct 6.

19.

Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity.

Reséndiz-Hernández JM, Sansores RH, Hernández-Zenteno Rde J, Vargas-Alarcón G, Colín-Barenque L, Velázquez-Uncal M, Camarena A, Ramírez-Venegas A, Falfán-Valencia R.

Int J Chron Obstruct Pulmon Dis. 2015 Jun 29;10:1241-51. doi: 10.2147/COPD.S83298. eCollection 2015.

20.

SEPAR-ALAT Consensus Document on Antipneumoccal Vaccination in Smokers.

Jiménez Ruiz CA, Buljubasich D, Sansores R, Riesco Miranda JA, Guerreros Benavides A, Luhning S, Chatkin JM, Zabert G, de Granda Orive JI, Solano Reina S, Casas Herrera A, de Lucas Ramos P.

Arch Bronconeumol. 2015 Jul;51(7):350-4. doi: 10.1016/j.arbres.2014.12.003. Epub 2015 Jan 29. English, Spanish.

21.

Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.

Pérez-Rubio G, Jiménez-Valverde LO, Ramírez-Venegas A, Camarena Á, Sansores RH, Flores-Trujillo F, Reséndiz-Hernández JM, Falfán-Valencia R.

Arch Bronconeumol. 2015 Feb;51(2):80-85. doi: 10.1016/j.arbres.2014.09.010. Epub 2014 Nov 7. English, Spanish.

22.

Asthma Control and Cost in Latin America.

Gold LS, Montealegre F, Allen-Ramey FC, Jardim J, Sansores R, Sullivan SD.

Value Health Reg Issues. 2014 Dec;5:25-28. doi: 10.1016/j.vhri.2014.06.007. Epub 2014 Jul 18.

PMID:
29702783
23.

FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.

Ramírez-Venegas A, Sansores RH, Quintana-Carrillo RH, Velázquez-Uncal M, Hernandez-Zenteno RJ, Sánchez-Romero C, Velazquez-Montero A, Flores-Trujillo F.

Am J Respir Crit Care Med. 2014 Nov 1;190(9):996-1002. doi: 10.1164/rccm.201404-0720OC.

PMID:
25172140
24.

Electronic cigarettes. A position statement of the forum of international respiratory societies.

Schraufnagel DE, Blasi F, Drummond MB, Lam DC, Latif E, Rosen MJ, Sansores R, Van Zyl-Smit R; Forum of International Respiratory Societies.

Am J Respir Crit Care Med. 2014 Sep 15;190(6):611-8. doi: 10.1164/rccm.201407-1198PP.

PMID:
25006874
25.

From the authors.

Ramirez-Venegas A, Sansores RH, Camp PG, Paré PD, Coxson HO.

Eur Respir J. 2014 Jul;44(1):262-3. doi: 10.1183/09031936.00029614. No abstract available.

26.

FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.

Montaño M, Sansores RH, Becerril C, Cisneros J, González-Avila G, Sommer B, Ochoa L, Herrera I, Ramírez-Venegas A, Ramos C.

Respir Res. 2014 Jun 30;15:74. doi: 10.1186/1465-9921-15-74.

27.

Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma.

Gayosso-Gómez LV, Zárraga-Granados G, Paredes-Garcia P, Falfán-Valencia R, Vazquez-Manríquez ME, Martinez-Barrera LM, Castillo-Gonzalez P, Rumbo-Nava U, Guevara-Gutierrez R, Rivera-Bravo B, Ramirez-Venegas A, Sansores R, Negrete-Garcia MC, Ortiz-Quintero B.

EXCLI J. 2014 Jul 8;13:740-50. eCollection 2014.

28.

Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America.

Maspero JF, Jardim JR, Aranda A, Tassinari C P, Gonzalez-Diaz SN, Sansores RH, Moreno-Cantu JJ, Fish JE.

World Allergy Organ J. 2013 Nov 4;6(1):19. doi: 10.1186/1939-4551-6-19.

29.

Level of asthma control and healthcare utilization in Latin America.

Gold LS, Montealegre F, Allen-Ramey FC, Jardim J, Smith N, Sansores R, Sullivan SD.

Allergy. 2013 Nov;68(11):1463-6. doi: 10.1111/all.12237. Epub 2013 Oct 10.

PMID:
24117970
30.

COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women.

Camp PG, Ramirez-Venegas A, Sansores RH, Alva LF, McDougall JE, Sin DD, Paré PD, Müller NL, Silva CI, Rojas CE, Coxson HO.

Eur Respir J. 2014 Mar;43(3):725-34. doi: 10.1183/09031936.00206112. Epub 2013 Oct 10.

31.

Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.

Sansores RH, Ramírez-Venegas A, Hernández-Zenteno R, Mayar-Maya ME, Pérez-Bautista OG, Velázquez Uncal M.

Respir Med. 2013 Apr;107(4):580-6. doi: 10.1016/j.rmed.2012.12.010. Epub 2013 Jan 9.

32.

[Vision abnormalities associated to smoking. A systematic review related to a clinical case].

Sansores RH, Ramírez-Venegas A, Pérez-Bautista O, Bustos M.

Rev Invest Clin. 2012 Jan-Feb;64(1):89-101. Review. Spanish. No abstract available.

PMID:
22690534
33.

Can pictorial warning labels on cigarette packages address smoking-related health disparities? Field experiments in Mexico to assess pictorial warning label content.

Thrasher JF, Arillo-Santillán E, Villalobos V, Pérez-Hernández R, Hammond D, Carter J, Sebrié E, Sansores R, Regalado-Piñeda J.

Cancer Causes Control. 2012 Mar;23 Suppl 1:69-80. doi: 10.1007/s10552-012-9899-8. Epub 2012 Feb 15.

34.

Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease.

Vargas-Rojas MI, Ramírez-Venegas A, Limón-Camacho L, Ochoa L, Hernández-Zenteno R, Sansores RH.

Respir Med. 2011 Nov;105(11):1648-54. doi: 10.1016/j.rmed.2011.05.017. Epub 2011 Jul 16.

35.

Consumption of single cigarettes and quitting behavior: a longitudinal analysis of Mexican smokers.

Thrasher JF, Villalobos V, Barnoya J, Sansores R, O'Connor R.

BMC Public Health. 2011 Feb 25;11:134. doi: 10.1186/1471-2458-11-134.

36.

[Proposal of Latin-American guidelines for smoking cessation].

Sansores RH, Pérez-Bautista O, Ramírez-Venegas A.

Salud Publica Mex. 2010;52 Suppl 2:S355-65. Review. Spanish.

PMID:
21243209
37.

[Anxiety and depression in Mexican smokers, and their relationship with the severity of addiction].

Urdapilleta-Herrera Edel C, Sansores RH, Ramírez-Venegas A, Méndez-Guerra M, Lara-Rivas AG, Guzmán-Barragán SA, Ayala-Guerrero F, Haro-Valencia R, Cansino S, Moreno-Coutiño A.

Salud Publica Mex. 2010;52 Suppl 2:S120-8. Spanish.

PMID:
21243182
38.

[Respiratory health and the National Institute of Respiratory Diseases].

Pérez-Padilla R, Sansores RH.

Rev Invest Clin. 2010 May-Jun;62(3):197-9. Spanish. No abstract available. Erratum in: Rev Invest Clin. 2010 Jul-Aug;62(4):384.

PMID:
20815123
39.

Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking.

Montaño M, Cisneros J, Ramírez-Venegas A, Pedraza-Chaverri J, Mercado D, Ramos C, Sansores RH.

Inhal Toxicol. 2010 Aug;22(10):868-74. doi: 10.3109/08958378.2010.491840.

PMID:
20583895
40.

[Differences in inflammatory markers in a non-smoking and smoking Mexican population].

Pérez-Bautista O, Ramírez-Venegas A, Escobar-Arriaga E, Sansores RH.

Rev Invest Clin. 2009 May-Jun;61(3):205-11. Spanish.

PMID:
19736809
41.

Cell proliferation kinetics and genotoxicity in lymphocytes of smokers living in Mexico City.

Calderón-Ezquerro C, Sánchez-Reyes A, Sansores RH, Villalobos-Pietrini R, Amador-Muñoz O, Guerrero-Guerra C, Calderón-Segura ME, Uribe-Hernández R, Gómez-Arroyo S.

Hum Exp Toxicol. 2007 Sep;26(9):715-22.

PMID:
17984142
42.

The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women.

Regalado J, Pérez-Padilla R, Sansores R, Páramo Ramirez JI, Brauer M, Paré P, Vedal S.

Am J Respir Crit Care Med. 2006 Oct 15;174(8):901-5. Epub 2006 Jun 23.

PMID:
16799080
43.

Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco.

Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, Regalado J, Velázquez A, Sánchez C, Mayar ME.

Am J Respir Crit Care Med. 2006 Feb 15;173(4):393-7. Epub 2005 Dec 1.

PMID:
16322646
44.

Matrix metalloproteinases activity in COPD associated with wood smoke.

Montaño M, Beccerril C, Ruiz V, Ramos C, Sansores RH, González-Avila G.

Chest. 2004 Feb;125(2):466-72.

PMID:
14769726
45.

Effect of the combination of two bronchodilators on breathlessness in patients with chronic obstructive pulmonary disease. A crossover clinical trial.

Sansores R, Ramírez-Vanegas A, Reddy C, Mejía-Alfaro R.

Arch Med Res. 2003 Jul-Aug;34(4):292-7.

PMID:
12957526
46.

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.

Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H.

Eur Respir J. 2003 Jan;21(1):74-81. Erratum in: Eur Respir J. 2003 May;21(5):912.

47.

Sexual content of advertisements and the smoking process in adolescents.

Sansores RH, Giraldo-Buitrago G, Reddy C, Ramírez-Venegas A.

Chest. 2002 Jun;121(6):2016-22.

PMID:
12065370
48.

[Treatments to quit smoking, available in Mexico].

Sansores RH, Ramírez-Venegas A, Espinosa-Martínez M, Sandoval RA.

Salud Publica Mex. 2002;44 Suppl 1:S116-24. Spanish.

PMID:
12055734
49.

[Impact of mass communication media on an anti-smoking campaign].

Sansores RH, Giraldo-Buitrago F, Valdelamar-Vázquez F, Ramírez-Venegas A, Sandoval RA.

Salud Publica Mex. 2002;44 Suppl 1:S101-8. Spanish.

PMID:
12055731
50.

Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population.

Guo X, Lin HM, Lin Z, Montaño M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J.

Eur Respir J. 2001 Sep;18(3):482-90.

Supplemental Content

Loading ...
Support Center